Scroll Back to Top
Contact Us
Case Study

Improving spirometry data integrity: The collaborative role of AI-enabled signal detection and independent clinical review

Download PDF

Fortrea was supporting a biotech sponsor in its Phase III global clinical trial for chronic obstructive pulmonary disease (COPD). With three studies, each enrolling more than 3,000 participants, the sponsor wanted to evaluate its initial spirometry study data by piloting a third-party AI tool.

Book a Meeting

Choose how you like to connect.

We've been driving innovation with our tailored clinical solutions for 30+ years. Let's connect.

Write to us
Book a Meeting

Prefer to send an inquiry?

Tell us about your needs and our team will follow up shortly.

* denotes required fields

Service Interest(s) *
(Word, PDF, PPT, Excel, Image)
One file only.
60 MB limit.
Allowed types: gif jpg jpeg png bmp txt rtf html pdf doc docx ppt pptx xls xlsx xml.

I agree to be contacted about products and services and receive other communications from Fortrea Inc. Please review Fortrea's Privacy Policy for further information. By submitting below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

By clicking submit below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

Explore Careers at Fortrea

Join our Site Network

Learn more about participating in a Fortrea Clinical Trial

Schedule a time with a Fortrea Specialist

Connect with our team to discuss your needs and explore the right solutions for your clinical development goals — quick, clear, and hassle‑free.

Book a Meeting